A.J. Bradbury

447 total citations
19 papers, 353 citations indexed

About

A.J. Bradbury is a scholar working on Cellular and Molecular Neuroscience, Neurology and Physiology. According to data from OpenAlex, A.J. Bradbury has authored 19 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 8 papers in Neurology and 4 papers in Physiology. Recurrent topics in A.J. Bradbury's work include Neuroscience and Neuropharmacology Research (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). A.J. Bradbury is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). A.J. Bradbury collaborates with scholars based in United Kingdom, Switzerland and Taiwan. A.J. Bradbury's co-authors include B. Costall, R.J. Naylor, M.E. Kelly, C. D. Marsden, Peter Jenner, A.M. Domeney, J. A. Smith, Robert J. Naylor, E.S. Onaivi and Joseph G. Cannon and has published in prestigious journals such as Nature, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

A.J. Bradbury

19 papers receiving 342 citations

Peers

A.J. Bradbury

CMN

NEURO

PMH

PHYSI

N. Turle-Lorenzo France

Stanisław Wolfarth Poland

George Carr Canada

Trina A. Wemlinger United States

Bethany S. Neal‐Beliveau United States

Leonard Katz United States

Gessa Gl Italy

Enrica Mosca Italy

P. R. Mitchell United Kingdom

Clint D. Anderson United States

N. Turle-Lorenzo France

A.J. Bradbury

302 ×1.3

CMN

149 ×0.9

NEURO

150 ×1.9

19 ×0.5

PMH

28 ×0.9

PHYSI

Citations per year, relative to A.J. Bradbury A.J. Bradbury (= 1×) peers N. Turle-Lorenzo

Countries citing papers authored by A.J. Bradbury

Since Specialization

Citations

This map shows the geographic impact of A.J. Bradbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.J. Bradbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.J. Bradbury more than expected).

Fields of papers citing papers by A.J. Bradbury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.J. Bradbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.J. Bradbury. The network helps show where A.J. Bradbury may publish in the future.

Co-authorship network of co-authors of A.J. Bradbury

This figure shows the co-authorship network connecting the top 25 collaborators of A.J. Bradbury. A scholar is included among the top collaborators of A.J. Bradbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.J. Bradbury. A.J. Bradbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Bradbury, A.J., B. Costall, R.J. Naylor, & E.S. Onaivi. (1987). 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse. Psychopharmacology. 93(4). 457–65. 26 indexed citations

Gunning, Simon J., A.J. Bradbury, B. Costall, & R.J. Naylor. (1986). Evidence that 5-hydroxytryptamine may exert both facilitatory and inhibitory control of electrical field stimulation-evoked contractions in longitudinal muscle taken from the body of guinea-pig stomach. Journal of Pharmacy and Pharmacology. 38(3). 182–187. 7 indexed citations

Bradbury, A.J., B. Costall, Peter Jenner, et al.. (1986). MPP+ can disrupt the nigrostriatal dopamine system by acting in the terminal area. Neuropharmacology. 25(8). 939–941. 19 indexed citations

Bradbury, A.J., B. Costall, A.M. Domeney, et al.. (1986). The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra. Neuroscience Letters. 67(2). 208–212. 9 indexed citations

Bradbury, A.J., B. Costall, A.M. Domeney, et al.. (1986). 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Nature. 319(6048). 56–57. 88 indexed citations

Bradbury, A.J., A. BROSSI, B. Costall, et al.. (1986). Biochemical changes caused by the infusion into the substantia nigra of the rat of MPTP and related compounds which antagonise dihydropteridine reductase. Neuropharmacology. 25(6). 583–586. 4 indexed citations

Bradbury, A.J., B. Costall, Peter Jenner, et al.. (1986). The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice antagonism by monoamine oxidase inhibitors. Neuropharmacology. 25(8). 897–904. 29 indexed citations

Bradbury, A.J., B. Costall, Peter Jenner, et al.. (1985). The neurotoxic actions of 1-methyl-4-phenylpyridine (MPP+) are not prevented by deprenyl treatment. Neuroscience Letters. 58(2). 177–181. 11 indexed citations

Bradbury, A.J., B. Costall, M.E. Kelly, R.J. Naylor, & J. A. Smith. (1985). Biochemical correlates of motor changes caused by the manipulation of dopamine function in the substantia nigra of the mouse. Neuropharmacology. 24(12). 1155–1161. 11 indexed citations

10.

Bradbury, A.J., et al.. (1985). Inhibition of Serum Melatonin Concentration and Synthesis of Brain Indolealkylamines by Monofluoromethyldopa in the Rat. Journal of Pineal Research. 2(2). 169–176. 5 indexed citations

11.

Bradbury, A.J., B. Costall, A.M. Domeney, et al.. (1985). The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety. Neuroscience Letters. 61(1-2). 121–126. 30 indexed citations

12.

Bradbury, A.J., B. Costall, A.M. Domeney, & R.J. Naylor. (1985). Laterality of dopamine function and neuroleptic action in the amygdala in the rat. Neuropharmacology. 24(12). 1163–1170. 28 indexed citations

13.

Bradbury, A.J., M.E. Kelly, & J. A. Smith. (1984). Melatonin action in the mid-brain can regulate forebrain dop amine function both behaviourally and biochemically. Journal of Steroid Biochemistry. 20(6). 1444–1444. 12 indexed citations

14.

Bradbury, A.J., Joseph G. Cannon, B. Costall, & Robert J. Naylor. (1984). A comparison of dopamine agonist action to inhibit locomotor activity and to induce stereotyped behaviour in the mouse. European Journal of Pharmacology. 105(1-2). 33–47. 24 indexed citations

15.

Bradbury, A.J., B. Costall, & R.J. Naylor. (1984). Inhibition and facilitation of motor responding of the mouse by actions of dopamine agonists in the forebrain. Neuropharmacology. 23(9). 1025–1031. 11 indexed citations

16.

Bradbury, A.J., B. Costall, & R.J. Naylor. (1983). Reduction in motor responding of the mouse by actions of dopamine agonists in the midbrain. Neuropharmacology. 22(10). 1171–1176. 19 indexed citations

17.

Bradbury, A.J., B. Costall, Robert J. Naylor, & John L. Neumeyer. (1983). Motor inhibition induced by aporphine derivatives in the mouse. Journal of Pharmacy and Pharmacology. 35(8). 494–499. 6 indexed citations

18.

Bradbury, A.J., B. Costall, & R.J. Naylor. (1983). Ascorbic acid and membrane ageing: critical determinants of the in-vitro binding of [3]ADTN to rat striatal tissue. Journal of Pharmacy and Pharmacology. 35(11). 738–745. 3 indexed citations

19.

Bradbury, A.J., et al.. (1982). Dystonia associated with carbamazepine toxicity. Postgraduate Medical Journal. 58(682). 525–526. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact